See more : ALBIS Co.,Ltd. (7475.T) Income Statement Analysis – Financial Results
Complete financial analysis of Pharmarise Holdings Corporation (2796.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pharmarise Holdings Corporation, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Volkswagen AG (VLKPF) Income Statement Analysis – Financial Results
- Star Equity Holdings, Inc. (STRR) Income Statement Analysis – Financial Results
- FFW Corporation (FFWC) Income Statement Analysis – Financial Results
- Nix, Inc. (4243.T) Income Statement Analysis – Financial Results
- Musk Metals Corp. (MUSK.CN) Income Statement Analysis – Financial Results
Pharmarise Holdings Corporation (2796.T)
About Pharmarise Holdings Corporation
Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54.47B | 52.03B | 51.61B | 52.32B | 51.03B | 51.73B | 54.56B | 52.95B | 48.51B | 39.51B | 38.22B | 33.36B | 29.61B | 26.83B | 23.42B | 20.01B | 18.58B |
| Cost of Revenue | 46.02B | 43.90B | 43.49B | 44.26B | 43.59B | 44.39B | 46.61B | 45.73B | 41.58B | 33.13B | 32.21B | 28.41B | 25.16B | 22.72B | 20.22B | 17.51B | 16.35B |
| Gross Profit | 8.45B | 8.13B | 8.12B | 8.07B | 7.44B | 7.34B | 7.95B | 7.22B | 6.93B | 6.38B | 6.01B | 4.94B | 4.45B | 4.10B | 3.19B | 2.49B | 2.22B |
| Gross Profit Ratio | 15.51% | 15.63% | 15.73% | 15.42% | 14.58% | 14.19% | 14.57% | 13.63% | 14.29% | 16.14% | 15.73% | 14.82% | 15.04% | 15.30% | 13.64% | 12.46% | 11.97% |
| Research & Development | 12.00M | 13.00M | 10.00M | 21.00M | 9.00M | 13.00M | 13.00M | 8.00M | 7.64M | 7.00M | 13.00M | 14.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 292.00M | 271.00M | 368.00M | 349.00M | 359.00M | 427.00M | 458.00M | 454.00M | 362.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 3.37B | 3.20B | 3.30B | 3.20B | 3.23B | 2.49B | 1.94B | 1.90B | 1.52B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.37B | 3.73B | 3.53B | 3.67B | 3.47B | 3.67B | 3.55B | 3.59B | 2.92B | 2.40B | 2.35B | 1.88B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 3.15B | 32.00M | -7.00M | 21.00M | 24.00M | -15.00M | 6.77B | 96.00M | 76.50M | 63.25M | -103.17M | 28.38M | -70.36M | -39.45M | -115.22M | -55.31M | -64.53M |
| Operating Expenses | 7.53B | 6.70B | 6.60B | 6.82B | 6.40B | 6.70B | 6.77B | 6.78B | 6.12B | 5.23B | 4.44B | 3.53B | 2.79B | 2.61B | 2.21B | 1.95B | 1.73B |
| Cost & Expenses | 53.55B | 50.59B | 50.09B | 51.08B | 49.99B | 51.09B | 53.38B | 52.51B | 47.70B | 38.36B | 36.65B | 31.95B | 27.95B | 25.33B | 22.43B | 19.47B | 18.08B |
| Interest Income | 1.00M | 1.00M | 1.00M | 1.00M | 2.00M | 3.00M | 6.00M | 5.00M | 7.03M | 5.43M | 7.18M | 5.58M | 4.93M | 5.93M | 9.06M | 7.08M | 7.74M |
| Interest Expense | 66.00M | 55.00M | 65.00M | 75.00M | 74.00M | 82.00M | 106.00M | 127.00M | 160.73M | 177.32M | 203.04M | 178.62M | 135.52M | 133.59M | 99.48M | 83.75M | 91.38M |
| Depreciation & Amortization | 1.17B | 1.22B | 1.31B | 1.34B | 1.23B | 1.22B | 1.33B | 1.29B | 1.20B | 1.16B | 1.08B | 835.84M | 672.10M | 603.04M | 448.89M | 395.26M | 352.96M |
| EBITDA | 2.09B | 2.66B | 2.83B | 2.59B | 2.26B | 1.86B | 2.51B | 1.78B | 2.38B | 2.28B | 2.44B | 2.65B | 2.24B | 1.91B | 1.13B | 912.82M | 790.24M |
| EBITDA Ratio | 3.83% | 5.18% | 5.47% | 5.00% | 4.45% | 3.55% | 4.59% | 3.29% | 4.16% | 5.91% | 6.61% | 6.72% | 7.69% | 7.75% | 5.64% | 4.43% | 4.25% |
| Operating Income | 916.00M | 1.44B | 1.52B | 1.25B | 1.03B | 640.00M | 1.18B | 442.00M | 813.15M | 1.14B | 1.57B | 1.41B | 1.66B | 1.50B | 982.84M | 539.84M | 494.08M |
| Operating Income Ratio | 1.68% | 2.76% | 2.95% | 2.38% | 2.03% | 1.24% | 2.16% | 0.83% | 1.68% | 2.89% | 4.11% | 4.23% | 5.60% | 5.58% | 4.20% | 2.70% | 2.66% |
| Total Other Income/Expenses | -773.00M | -389.00M | -198.00M | -44.00M | -215.00M | -240.00M | -765.00M | -441.00M | 212.00M | -199.87M | -416.59M | 219.43M | -221.78M | -324.64M | -402.20M | -97.22M | -231.63M |
| Income Before Tax | 143.00M | 1.05B | 1.32B | 1.20B | 819.00M | 400.00M | 414.00M | 1.00M | 1.02B | 943.45M | 1.16B | 1.63B | 1.44B | 1.17B | 580.65M | 442.37M | 262.45M |
| Income Before Tax Ratio | 0.26% | 2.02% | 2.56% | 2.30% | 1.60% | 0.77% | 0.76% | 0.00% | 2.11% | 2.39% | 3.02% | 4.89% | 4.85% | 4.37% | 2.48% | 2.21% | 1.41% |
| Income Tax Expense | 485.00M | 702.00M | 863.00M | 782.00M | 238.00M | 409.00M | 622.00M | 251.00M | 655.49M | 714.90M | 778.88M | 666.96M | 739.74M | 598.68M | 296.94M | 216.96M | 161.19M |
| Net Income | -351.00M | 333.00M | 447.00M | 426.00M | 577.00M | 23.00M | -208.00M | 7.00M | 382.20M | 227.89M | 369.09M | 958.00M | 685.82M | 562.98M | 276.58M | 222.51M | 96.53M |
| Net Income Ratio | -0.64% | 0.64% | 0.87% | 0.81% | 1.13% | 0.04% | -0.38% | 0.01% | 0.79% | 0.58% | 0.97% | 2.87% | 2.32% | 2.10% | 1.18% | 1.11% | 0.52% |
| EPS | -33.35 | 35.42 | 47.90 | 45.78 | 61.03 | 2.51 | -23.01 | 0.85 | 42.44 | 25.31 | 46.55 | 127.73 | 91.44 | 88.78 | 43.12 | 103.06 | 14.99 |
| EPS Diluted | -33.35 | 26.86 | 36.22 | 34.59 | 46.32 | 2.12 | -23.01 | 0.83 | 41.55 | 24.99 | 46.31 | 127.73 | 91.44 | 88.78 | 43.12 | 103.06 | 14.99 |
| Weighted Avg Shares Out | 10.52M | 9.40M | 9.33M | 9.31M | 9.45M | 9.15M | 9.04M | 9.03M | 9.01M | 9.00M | 7.93M | 7.50M | 7.50M | 6.34M | 6.41M | 2.14M | 6.44M |
| Weighted Avg Shares Out (Dil) | 10.52M | 12.47M | 12.40M | 12.37M | 12.50M | 10.84M | 9.04M | 9.03M | 9.19M | 9.12M | 7.97M | 7.50M | 7.50M | 6.34M | 6.41M | 2.14M | 6.44M |
Source: https://incomestatements.info
Category: Stock Reports